Paris: The drug delivery and packaging industry is poised for a promising 2024, following the highly anticipated Pharmapack Europe – the event at heart of the drug delivery and packaging industry held on January 24th and 25th – where executives were in buoyant mood, with a strong year for growth now expected.

Pharmapack recorded a joint record attendance of 5,500 and saw a strong resurgence in industry confidence in the Pharmapack Index; many new innovations in the largest ever Pharmapack Awards and Start up Hub; and a proliferation in industry dealmaking and partnering. In total there were 370+ exhibitors from more than 80 countries.

With an increasing global demand for innovative drug delivery systems and efficient healthcare packaging, Pharmapack Europe plays a vital role in advancing the industry. The conference brings together professionals and experts from pharmaceutical companies, packaging manufacturers and regulatory bodies to exchange knowledge, showcase the latest advancements and foster collaborations.

This year's Pharmapack Europe witnessed a 13% rise in attendance and a high turnout is seen as a strong positive signal for the drug delivery and packaging prospects. Exhibitors from around the world showcased their cutting-edge solutions, ranging from intelligent packaging, tracking solutions and supply chain innovations to next-generation injectors, on-body devices, novel caps and plastics, and reusable digital add-on devices.

“Pharmapack was once again very successful for Gerresheimer and a great opportunity to meet prospects, customers, and partners. For presenting our broad portfolio of Systems and Solutions to the pharma and biotech industry, exploring market trends and networking. Pharmapack is a very important event for us.” Ueli Utzinger, Group Senior Director Communication & Marketing Gerresheimer AG

Industry collaboration emerged as a central theme throughout Pharmapack Europe. Collaborative efforts among pharmaceutical companies, packaging manufacturers, device makers and component suppliers are integral to bringing about the newer patient-centered solutions that enhanced adherence.

“Pharmapack Europe 2024 was a tremendous success and all our stakeholder’s reported confidence in the year ahead, not least, due to the large turnout across the two days. The other notable feedback we received was the importance of collaboration and using the event to facilitate new learnings and an exchange of knowledge – so central to helping the industry advance more quickly. So, if I was to some-up our feedback from industry in just a few words, it would be ‘buddling confidence for innovation, partnering and growth’”, commented Laura Indriksone, Brand Manager at Pharmapack Europe.